117
Participants
Start Date
December 12, 2018
Primary Completion Date
September 26, 2023
Study Completion Date
September 26, 2023
BOS172738
Oral capsules
Fox Chase Cancer Center, Philadelphia
Hospital Universitario Virgen de la Victoria, Málaga
MD Anderson Cancer Center, Houston
Institut Jules Bordet, Brussels
UZ Leuven, Leuven
Institut Bergonié, Bordeaux
Centre Léon Bérard, Lyon
Hôpital Pitié-Salpêtrière, Paris
Institut Gustave Roussy, Villejuif
Prince of Wales Hospital, Hong Kong
Chungbuk National University Hospital, Cheongju-si
Seoul National University Bundang Hospital, Gyeonggi-do
Asan Medical Center, Seoul
Korea University Anam Hospital, Seoul
Severance Hospital, Yonsei University College of Medicine, Seoul
Hospital Germans Trias i Pujol, Badalona
Instituto Oncológico Dr. Rosell, S.L., Barcelona
Start Madrid - Ciocc, Madrid
START MADRID-FJD, Hospital Fundación Jiménez Díaz, Madrid
Taichung Veterans General Hospital, Taichung
National Taiwan University Hospital, Taipei
Lead Sponsor
Boston Pharmaceuticals
INDUSTRY